Find a Study

STUDY SEARCH RESULTS

Notify Me When Search is Updated

358 studies found for your search request: cancer

18F-FLT-PET in Breast Cancer (MK-0000-139)
Condition: Breast Cancer
Minimum Age: 35 years, Maximum Age: 75 years
Gender: Female
Study ID: NCT01015131
Status: Completed

A clinical study of MK-2870 alone or with chemotherapy to treat gastrointestinal cancers (MK-9999-02...
Condition: Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06428409
Status: Recruiting
Has Enrolling Locations in US or Canada

A clinical study of Pembrolizumab (+) Berahyaluronidase alfa (MK-3475A) to treat newly-diagnosed met...
Condition: Lung Cancer, Non-Small Cell Lung Cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06698042
Status: Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients with Bladder Cancer (MK-2870-027)
Condition: Non-Muscle Invasive Bladder Cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06637423
Status: Recruiting
Has Enrolling Locations in US or Canada

A Clinical Study of V940 plus Pembrolizumab in People with High-Risk Melanoma (V940-001)
Condition: Melanoma
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT05933577
Status: Active, not recruiting

Copyright © 2025 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences Privacy Terms of Use Consumer Health Data Privacy Policy Your Privacy Choices Accessibility U.S. Corporate Site